etoposide has been researched along with alpha-aminopyridine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 6 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, WM; Chen, Z; Dou, J; Guan, S; Liu, S; Nuchtern, JG; Pang, JC; Patel, R; Shi, Y; Vasudevan, SA; Wang, L; Wang, Y; Xu, X; Yang, J; Yang, T; Yao, D; Yu, Y; Zhang, H; Zhao, Y | 1 |
| Chmielewska, K; Kluska, M; Pietrzak, J; Robaszkiewicz, A; Rygielska, Ż; Tempka, D; Tokarz, P; Virág, L | 1 |
| Che, Y; Ding, X; Song, J; Sun, X; Xu, L; Zhang, X | 1 |
| Chen, Z; Li, Y; Tian, C | 1 |
| Chung, JS; Kim, DY; Kim, SW; Nam, J; Shin, HJ | 1 |
| Chen, Z; Feng, X; Gao, Y; Li, H; Li, Z; Shi, C; Song, W; Zhang, M | 1 |
| Dong, T; Jing, F; Song, W; Wang, L; Wang, Y; Xiao, S; Xue, H | 1 |
| Cai, Q; Song, W; Sun, X; Wang, L; Wang, Y; Xue, H; Zhang, H; Zhang, L; Zhang, M; Zou, L | 1 |
| He, ZD; Hong, HY; Li, MW; Peng, ZG; Xu, QY; Yang, HY | 1 |
1 review(s) available for etoposide and alpha-aminopyridine
| Article | Year |
|---|---|
Sintilimab combined with chidamide in the treatment of extranodal nature killer/T-cell lymphoma with secondary hemophagocytic lymphohistiocytosis: Two case reports and literature review.
Topics: Aminopyridines; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Etoposide; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma, Extranodal NK-T-Cell; Methylprednisolone; Oxaliplatin | 2022 |
1 trial(s) available for etoposide and alpha-aminopyridine
| Article | Year |
|---|---|
Chidamide plus prednisone, etoposide, and thalidomide for untreated angioimmunoblastic T-cell lymphoma in a Chinese population: A multicenter phase II trial.
Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Etoposide; Humans; Lymphoma, T-Cell, Peripheral; Neutropenia; Prednisone; Thalidomide; Treatment Outcome | 2022 |
7 other study(ies) available for etoposide and alpha-aminopyridine
| Article | Year |
|---|---|
Wip1 inhibitor GSK2830371 inhibits neuroblastoma growth by inducing Chk2/p53-mediated apoptosis.
Topics: Aminopyridines; Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Checkpoint Kinase 2; Dipeptides; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Mice; Neuroblastoma; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2016 |
Downregulation of PARP1 transcription by CDK4/6 inhibitors sensitizes human lung cancer cells to anticancer drug-induced death by impairing OGG1-dependent base excision repair.
Topics: Aminopyridines; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclin-Dependent Kinase 4; Daunorubicin; DNA Damage; DNA Glycosylases; DNA Repair; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Hydrogen Peroxide; Lung Neoplasms; Piperazines; Poly (ADP-Ribose) Polymerase-1; Promoter Regions, Genetic; Purines; Pyridines | 2018 |
Effective remission of chidamide on treatment of advanced mycosis fungoides: An unusual case report.
Topics: Adult; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cisplatin; Cyclophosphamide; Etoposide; Female; Humans; Mycosis Fungoides; Quality of Life; Skin Neoplasms; Treatment Outcome; Vincristine | 2019 |
Chidamide combined with ibrutinib improved the prognosis of primary bone marrow diffuse large B cell lymphoma.
Topics: Adenine; Aged; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Marrow; Bone Marrow Cells; China; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Piperidines; Prednisone; Prognosis; Rituximab; Transplantation, Autologous; Vincristine | 2020 |
Role of Roflumilast Combined with ESHAP Chemotherapy in Relapsed/Refractory Patients with Diffuse Large B-Cell Lymphoma.
Topics: Aged; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cisplatin; Cyclopropanes; Cytarabine; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Middle Aged; Phosphatidylinositol 3-Kinases; Phosphodiesterase 4 Inhibitors; Pilot Projects | 2022 |
Synergistic anticancer effect of a combination of chidamide and etoposide against NK/T cell lymphoma.
Topics: Aminopyridines; Benzamides; Cell Line, Tumor; Drug Synergism; Etoposide; Histone Deacetylase Inhibitors; Humans; Lymphoma, T-Cell, Peripheral | 2023 |
Chidamide with PEL regimen (prednisone, etoposide, lenalidomide) for elderly or frail patients with relapsed/refractory diffuse large B-Cell lymphoma -results of a single center, retrospective cohort in China.
Topics: Aged; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Etoposide; Frail Elderly; Histone Deacetylase Inhibitors; Humans; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Retrospective Studies; Rituximab | 2022 |